User Tools

Site Tools


cerebral_microbleed_etiology

Cerebral Microbleed Etiology

In patients with Cerebral large artery disease (CLAD), elevated plasma VEGF might be associated with Cerebral Microbleeds (CMBs), especially those located in the cortex and/or at the gray-white junction 1).

Cerebral microbleeds are common in older persons. The association with homozygote Apo E epsilon4 genotype and finding a relative predominance in the parietal lobes might indicate an association with amyloid angiopathy 2).

Cerebral microbleeds (CMBs), can result from traumatic brain injury.

Cerebral microbleeds (cMBs) have previously been linked with especially high incidence in Asian patients with moyamoya disease together with high tendency to bleed. This, presumably, is characteristic of patients with moyamoya.

Wenz et al., included all patients with moyamoya who underwent standard magnetic resonance imaging, including T2*-weighted images, in the Department of Neurosurgery, University of Heidelberg, Mannheim, Germany. between 1998 and 2015. Two independent readers evaluated magnetic resonance imaging scans to determine the occurrence of cMBs according to the Brain Observer Microbleed Scale. Demographics, initial symptoms leading to hospitalization, and associated diseases were obtained by chart review.

Overall, there was a total of 242 T2* studies of 101 included moyamoya patients available with a strong female predominance (69.3%). Eight patients (7.9%) were ≤18 years of age.

They detected 25 cMBs within 13 patients (12.9%). One patient <18 of age was presented with a cMB; 2 of 3 patients with an intracranial hemorrhage as initial event demonstrated cMB(s). In 72 of 101 cases, there were 1719 person months of follow-up, with 3 adult patients showing 3 de novo cMBs in the course. The majority of cMBs (64.0%) were located at the cortex/gray-white junction.

Although the frequency of cMBs herein is much higher than the expected age-specific incidence, it is still much lower compared with previous reports on cMBs in moyamoya patients of Asian descent. These results might reflect another ethnic-specific difference in patients diagnosed with moyamoya 3).

1)
Ogata T, Dohgu S, Takano K, Inoue T, Arima H, Takata F, Kataoka Y, Tsuboi Y. Increased Plasma VEGF Levels in Patients with Cerebral Large Artery Disease Are Associated with Cerebral Microbleeds. Cerebrovasc Dis Extra. 2019 Apr 30;9(1):25-30. doi: 10.1159/000497215. [Epub ahead of print] PubMed PMID: 31039570.
2)
Sveinbjornsdottir S, Sigurdsson S, Aspelund T, Kjartansson O, Eiriksdottir G, Valtysdottir B, Lopez OL, van Buchem MA, Jonsson PV, Gudnason V, Launer LJ. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1002-6. doi: 10.1136/jnnp.2007.121913. PubMed PMID: 18270235.
3)
Wenz H, Wenz R, Maros M, Ehrlich G, Al-Zghloul M, Groden C, Förster A. Incidence, Locations, and Longitudinal Course of Cerebral Microbleeds in European Moyamoya. Stroke. 2017 Jan 6. pii: STROKEAHA.116.014335. doi: 10.1161/STROKEAHA.116.014335. [Epub ahead of print] PubMed PMID: 28062861.
cerebral_microbleed_etiology.txt · Last modified: 2019/05/01 12:11 by administrador